BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 4103749)

  • 1. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
    Furth ED; Dentinger M
    Endocrinology; 1971 Jul; 89(1):310-5. PubMed ID: 4103749
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of immunization of rabbits with human thyroglobulin and human and rabbit thyroid microsomal fractions.
    Beall GN; Chopra IJ; Solomon DH
    Clin Exp Immunol; 1971 Apr; 8(4):647-56. PubMed ID: 5576294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes.
    Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1968 Apr; 28(4):503-10. PubMed ID: 4868496
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
    Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of immunization of baboons with human thyroid tissue.
    Beall GN; Daniel PM; Pratt OE; Solomon DH
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1460-9. PubMed ID: 4981680
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid gland in Graves' disease: victim or culprit?
    Chopra IJ; Solomon DH; Johnson DE; Chopra U
    Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental production of a thyroid-stimulating antithyroid antibody.
    McKenzie JM
    J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
    [No Abstract]   [Full Text] [Related]  

  • 8. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
    Orgiazzi J; Pousset G; Durand H
    Presse Med (1893); 1971 May; 79(25):1167-8. PubMed ID: 4933634
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
    Wong ET; Doe RP
    Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
    [No Abstract]   [Full Text] [Related]  

  • 10. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1095-102. PubMed ID: 4166580
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioisotopic thyroidolymphography in patients with Graves' disease.
    Kriss JP
    J Clin Endocrinol Metab; 1970 Sep; 31(3):315-23. PubMed ID: 4916540
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
    Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
    J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
    Adlkofer F; Schleusener H; Uher L; Ananos A
    Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
    [No Abstract]   [Full Text] [Related]  

  • 16. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
    Izumi M; Larsen PR
    J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of the McKenzie bioassay.
    Florsheim WH; Williams AD; Schönbaum E
    Endocrinology; 1970 Nov; 87(5):881-8. PubMed ID: 5536603
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-acting thyroid stimulator and thyroid function in relatives of patients with Graves' disease.
    Bonnyns M; Vanhaerlst L; Golstein J; Cauchie C; Ermans AM; Bastenie PA
    Clin Endocrinol (Oxf); 1973 Jul; 2(3):277-87. PubMed ID: 4128244
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of thyroglobulin on thyroid function.
    Burke G; Szabo M
    J Clin Endocrinol Metab; 1972 Oct; 35(4):552-60. PubMed ID: 4340789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.